HANXBIO-B (03378): Stabilization Period Concludes, No Price-Stabilizing Actions, and Over-Allotment Option Lapses

Stock News01-23

HANXBIO-B (03378) announced that the stabilization period relating to the global offering concluded on Saturday, January 17, 2026, which was the 30th day after the deadline for submitting applications under the Hong Kong public offering. Furthermore, the sponsor and overall coordinator, acting for itself and on behalf of the international underwriters, confirmed that the shares offered under the international offering were not over-allocated. Consequently, the over-allotment option was not exercised and lapsed on Saturday, January 17, 2026. The stabilizing agent informed the company that neither it nor any person acting on its behalf undertook any price-stabilizing actions during the stabilization period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment